|
Lipid and lipoprotein metabolism
Citations 341-350 of 549 total displayed.
|
Past content
(since Jan 1999):
|
- Clinical Investigations and Reports
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
- Mehdi H. Shishehbor, Marie-Luise Brennan, Ronnier J. Aviles, Xiaoming Fu, Marc S. Penn, Dennis L. Sprecher, and Stanley L. Hazen
Circulation 2003;108:426-431; published online before print as doi:10.1161/01.CIR.0000080895.05158.8B
[Abstract]
[Full text]
- Corrections
Correction
-
Circulation 2003;108:500, doi:10.1161/01.CIR.0000085816.06972.1A
[Full text]
- Corrections
Correction
-
Circulation 2003;108:501
[Full text]
- Editorials
Inflammation, Metabolic Syndrome, and Diet Responsiveness
- Scott M. Grundy
Circulation 2003;108:126-128, doi:10.1161/01.CIR.0000082641.20034.6A
[Full text]
- Clinical Investigations and Reports
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
- Mehdi H. Shishehbor, Marie-Luise Brennan, Ronnier J. Aviles, Xiaoming Fu, Marc S. Penn, Dennis L. Sprecher, and Stanley L. Hazen
Circulation published July 14, 2003, doi:10.1161/01.CIR.0000080895.05158.8B
[Abstract]
- Correspondence
Inflammatory Markers in Coronary Heart Disease: Coronary Vascular Versus Myocardial Origin? • Response
- Gerd Heusch, Rainer Schulz, Raimund Erbel, Thomas A. Pearson, George A. Mensah, R. Wayne Alexander, Jeffrey L. Anderson, Richard O. Cannon, III, Michael H. Criqui, Yazid Y. Fadl, Stephen P. Fortmann, Yuling Hong, Gary L. Myers, Nader Rifai, Sidney C. Smith, Jr, Kathryn Taubert, Russell P. Tracy, and Frank Vinicor
Circulation 2003;108:e4, doi:10.1161/01.CIR.0000079055.99427.3F
[Full text]
- Correspondence
Randomized Controlled Trial Evidence That Estrogen Replacement Therapy Reduces the Progression of Subclinical Atherosclerosis in Healthy Postmenopausal Women Without Preexisting Cardiovascular Disease • Response
- Howard N. Hodis, Wendy J. Mack, Roger A. Lobo, David M. Herrington, Timothy D. Howard, Bridget Brosnihan, Gregory A. Hawkins, David M. Reboussin, Jianfeng Xu, Siqun L. Zheng, Deborah A. Meyers, Eugene R. Bleeker, Donald P. McDonnell, and Xiaolin Li
Circulation 2003;108:e5, doi:10.1161/01.CIR.0000080080.76333.38
[Full text]
- Basic Science Reports
Platelet-Activating Factor Acetylhydrolase Is Mainly Associated With Electronegative Low-Density Lipoprotein Subfraction
- Sonia Benítez, José Luis Sánchez-Quesada, Vicent Ribas, Oscar Jorba, Francisco Blanco-Vaca, Francesc González-Sastre, and Jordi Ordóñez-Llanos
Circulation 2003;108:92-96; published online before print as doi:10.1161/01.CIR.0000072791.40232.8F
[Abstract]
[Full text]
- Clinician Update
Perspectives in Cholesterol-Lowering Therapy: The Role of Ezetimibe, a New Selective Inhibitor of Intestinal Cholesterol Absorption
- Eric Bruckert, Philippe Giral, and Philippe Tellier
Circulation 2003;107:3124-3128, doi:10.1161/01.CIR.0000072345.98581.24
[Full text]
- Correspondence
Isoprostanes: Are They More Than Physiopathological Biomarkers of Lipid Peroxidation? • Response
- Jean-Luc Cracowski, Jean-Philippe Baguet, Pietro Minuz, Stefania Gaino, Maurizio Degan, Laura Menapace, Rosamaria Tommasoli, Giancarlo Mansueto, Enrico Arosio, Clara Lechi Santonastaso, Alessandro Lechi, Paola Patrignani, Francesca Seta, Marta L. Capone, Stefania Tacconelli, Carlo Patrono, Simone Palatresi, Chiara Bencini, Cecilia Del Vecchio, and Alberto Morganti
Circulation 2003;107:e222, doi:10.1161/01.CIR.0000077640.74263.82
[Full text]
|
|
